Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-25

Clinical Trial Update: Effects of AkPharma's Calcium Glycerophosphate Nasal Spray Wash [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 clinical trial evaluating AkPharma's calcium glycerophosphate nasal spray wash for allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcium glycerophosphate nasal spray wash (AkPharma) (calcium glycerophosphate nasal spray wash)

Snippet

Sponsor: Drexel University | Conditions: Allergic Rhinitis | Phase 1, Phase 2 | Status: COMPLETED